268 related articles for article (PubMed ID: 22976955)
1. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.
Rao S; Lee SY; Gutierrez A; Perrigoue J; Thapa RJ; Tu Z; Jeffers JR; Rhodes M; Anderson S; Oravecz T; Hunger SP; Timakhov RA; Zhang R; Balachandran S; Zambetti GP; Testa JR; Look AT; Wiest DL
Blood; 2012 Nov; 120(18):3764-73. PubMed ID: 22976955
[TBL] [Abstract][Full Text] [Related]
2. Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.
Rao S; Cai KQ; Stadanlick JE; Greenberg-Kushnir N; Solanki-Patel N; Lee SY; Fahl SP; Testa JR; Wiest DL
Cancer Res; 2016 Jun; 76(11):3387-96. PubMed ID: 27197189
[TBL] [Abstract][Full Text] [Related]
3. Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling.
Solanki NR; Stadanlick JE; Zhang Y; Duc AC; Lee SY; Lauritsen JP; Zhang Z; Wiest DL
J Immunol; 2016 Sep; 197(6):2280-9. PubMed ID: 27489283
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of ribosomal protein L22 in non-small cell lung cancer.
Yang M; Sun H; Wang H; Zhang S; Yu X; Zhang L
Med Oncol; 2013; 30(3):646. PubMed ID: 23797773
[TBL] [Abstract][Full Text] [Related]
5. Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint.
Fahl SP; Harris B; Coffey F; Wiest DL
J Immunol; 2015 Jan; 194(1):200-9. PubMed ID: 25416806
[TBL] [Abstract][Full Text] [Related]
6. Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs.
Zhang Y; Duc AC; Rao S; Sun XL; Bilbee AN; Rhodes M; Li Q; Kappes DJ; Rhodes J; Wiest DL
Dev Cell; 2013 Feb; 24(4):411-25. PubMed ID: 23449473
[TBL] [Abstract][Full Text] [Related]
7. The ribosomal protein Rpl22 controls ribosome composition by directly repressing expression of its own paralog, Rpl22l1.
O'Leary MN; Schreiber KH; Zhang Y; Duc AC; Rao S; Hale JS; Academia EC; Shah SR; Morton JF; Holstein CA; Martin DB; Kaeberlein M; Ladiges WC; Fink PJ; Mackay VL; Wiest DL; Kennedy BK
PLoS Genet; 2013; 9(8):e1003708. PubMed ID: 23990801
[TBL] [Abstract][Full Text] [Related]
8. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint.
Anderson SJ; Lauritsen JP; Hartman MG; Foushee AM; Lefebvre JM; Shinton SA; Gerhardt B; Hardy RR; Oravecz T; Wiest DL
Immunity; 2007 Jun; 26(6):759-72. PubMed ID: 17555992
[TBL] [Abstract][Full Text] [Related]
9. High frequency of RPL22 mutations in microsatellite-unstable colorectal and endometrial tumors.
Ferreira AM; Tuominen I; van Dijk-Bos K; Sanjabi B; van der Sluis T; van der Zee AG; Hollema H; Zazula M; Sijmons RH; Aaltonen LA; Westers H; Hofstra RM
Hum Mutat; 2014 Dec; 35(12):1442-5. PubMed ID: 25196364
[TBL] [Abstract][Full Text] [Related]
10. Interaction of ribosomal protein L22 with casein kinase 2α: a novel mechanism for understanding the biology of non-small cell lung cancer.
Yang M; Sun H; He J; Wang H; Yu X; Ma L; Zhu C
Oncol Rep; 2014 Jul; 32(1):139-44. PubMed ID: 24840952
[TBL] [Abstract][Full Text] [Related]
11. L22 ribosomal protein is involved in dynamin-related protein 1-mediated gastric carcinoma progression.
Cheng J; Sha Z; Zhang R; Ge J; Chen P; Kuang X; Chang J; Ren K; Luo X; Chen S; Gou X
Bioengineered; 2022 Mar; 13(3):6650-6664. PubMed ID: 35230214
[TBL] [Abstract][Full Text] [Related]
12. The effects of siRNA against RPL22 on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells.
Sun K; Xue H; Wang H; Wang Q; Zuo XR; Xie WP; Wang H
Int J Mol Med; 2012 Aug; 30(2):351-7. PubMed ID: 22580622
[TBL] [Abstract][Full Text] [Related]
13. Ribosomal proteins and the control of alphabeta T lineage development.
Murre C
Immunity; 2007 Jun; 26(6):751-2. PubMed ID: 17582347
[TBL] [Abstract][Full Text] [Related]
14. Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V(D)J recombination.
Rashkovan M; Vadnais C; Ross J; Gigoux M; Suh WK; Gu W; Kosan C; Möröy T
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5411-9. PubMed ID: 25468973
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal Proteins Rpl22 and Rpl22l1 Control Morphogenesis by Regulating Pre-mRNA Splicing.
Zhang Y; O'Leary MN; Peri S; Wang M; Zha J; Melov S; Kappes DJ; Feng Q; Rhodes J; Amieux PS; Morris DR; Kennedy BK; Wiest DL
Cell Rep; 2017 Jan; 18(2):545-556. PubMed ID: 28076796
[TBL] [Abstract][Full Text] [Related]
16. Frequent mutations in the RPL22 gene and its clinical and functional implications.
Novetsky AP; Zighelboim I; Thompson DM; Powell MA; Mutch DG; Goodfellow PJ
Gynecol Oncol; 2013 Mar; 128(3):470-4. PubMed ID: 23127973
[TBL] [Abstract][Full Text] [Related]
17. Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.
Beachy SH; Onozawa M; Chung YJ; Slape C; Bilke S; Francis P; Pineda M; Walker RL; Meltzer P; Aplan PD
Blood; 2012 Aug; 120(5):1048-59. PubMed ID: 22723554
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of 60S ribosomal protein L22 (RPL22) from Culex pipiens pallens.
He J; Sun H; Zhang D; Sun Y; Ma L; Chen L; Liu Z; Xiong C; Yan G; Zhu C
Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):216-22. PubMed ID: 19298862
[TBL] [Abstract][Full Text] [Related]
19. Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22.
Fok V; Mitton-Fry RM; Grech A; Steitz JA
RNA; 2006 May; 12(5):872-82. PubMed ID: 16556938
[TBL] [Abstract][Full Text] [Related]
20. Lin28 promotes transformation and is associated with advanced human malignancies.
Viswanathan SR; Powers JT; Einhorn W; Hoshida Y; Ng TL; Toffanin S; O'Sullivan M; Lu J; Phillips LA; Lockhart VL; Shah SP; Tanwar PS; Mermel CH; Beroukhim R; Azam M; Teixeira J; Meyerson M; Hughes TP; Llovet JM; Radich J; Mullighan CG; Golub TR; Sorensen PH; Daley GQ
Nat Genet; 2009 Jul; 41(7):843-8. PubMed ID: 19483683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
